This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Most Shorted Stocks in Biotech

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Avanir Pharmaceuticals (AVNR)

Short interest: 27%
52-week high: $5.80
Current price: $2.86
Year-to-date performance relative to the Nasdaq Biotechnology Index: Down 30%

Shorts have been laughing uncontrollably over the slow, slow, slow launch of Avanir's Nuedexta for pseudobulbar affect (PBA).

Just like the five stages of grief, analysts and Avanir investors have come to accept that Nuedexta isn't the blockbuster drug they thought it was. Revenue forecasts have been whacked to such an extent that Avanir has a decent shot of meeting, if not beating, expectations for the third quarter.

The longer-term problem for Avanir is that its sales reps have to visit doctors multiple times before doctors are convinced to give Nuedexta a try in the few PBA patients they have. Marketing Nuedexta costs so much money that Avanir may never reach profitability.

3 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SVNT $0.00 0.00%
BPAX $55.05 -1.24%
AVNR $16.96 0.00%
ONTY $1.72 0.00%
SGEN $36.13 0.00%


DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs